157 related articles for article (PubMed ID: 26806586)
1. Loss of T Follicular Helper Cells in the Peripheral Blood of Patients with Chronic Graft-versus-Host Disease.
Knorr DA; Wang H; Aurora M; MacMillan ML; Holtan SG; Bergerson R; Cao Q; Weisdorf DJ; Cooley S; Brunstein C; Miller JS; Wagner JE; Blazar BR; Verneris MR
Biol Blood Marrow Transplant; 2016 May; 22(5):825-33. PubMed ID: 26806586
[TBL] [Abstract][Full Text] [Related]
2. Aberrant germinal center formation, follicular T-helper cells, and germinal center B-cells were involved in chronic graft-versus-host disease.
Shao L; Lie AK; Zhang Y; Wong CH; Kwong YL
Ann Hematol; 2015 Sep; 94(9):1493-504. PubMed ID: 25963280
[TBL] [Abstract][Full Text] [Related]
3. Circulating T follicular helper cells with increased function during chronic graft-versus-host disease.
Forcade E; Kim HT; Cutler C; Wang K; Alho AC; Nikiforow S; Ho VT; Koreth J; Armand P; Alyea EP; Blazar BR; Soiffer RJ; Antin JH; Ritz J
Blood; 2016 May; 127(20):2489-97. PubMed ID: 26944544
[TBL] [Abstract][Full Text] [Related]
4. Expansion of circulating extrafollicular helper T-like cells in patients with chronic graft-versus-host disease.
Jin H; Yang K; Zhang H; Chen Y; Qi H; Fan Z; Huang F; Xuan L; Lin R; Zhao K; Liu Q
J Autoimmun; 2019 Jun; 100():95-104. PubMed ID: 30878167
[TBL] [Abstract][Full Text] [Related]
5. Targeting Bcl-6 prevents sclerodermatous chronic graft-versus-host disease by abrogating T follicular helper differentiation in mice.
Chen X; Wang Y; Huang X; Geng S; Li C; Zeng L; Huang L; Du X; Weng J; Lai P
Int Immunopharmacol; 2023 Apr; 117():109746. PubMed ID: 36827923
[TBL] [Abstract][Full Text] [Related]
6. Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans.
Flynn R; Du J; Veenstra RG; Reichenbach DK; Panoskaltsis-Mortari A; Taylor PA; Freeman GJ; Serody JS; Murphy WJ; Munn DH; Sarantopoulos S; Luznik L; Maillard I; Koreth J; Cutler C; Soiffer RJ; Antin JH; Ritz J; Dubovsky JA; Byrd JC; MacDonald KP; Hill GR; Blazar BR
Blood; 2014 Jun; 123(25):3988-98. PubMed ID: 24820310
[TBL] [Abstract][Full Text] [Related]
7. [The Role and Mechanism of Tfh and B Cell in Human Chronic Graft-Versus-Host-Disease].
Lyu KK; Xu MM; DU YY; He XF; Chen F; Ma X; Han Y; Wu DP; Liu YJ; Xu MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Apr; 30(2):593-599. PubMed ID: 35396002
[TBL] [Abstract][Full Text] [Related]
8. Targeting PI3Kδ function for amelioration of murine chronic graft-versus-host disease.
Paz K; Flynn R; Du J; Tannheimer S; Johnson AJ; Dong S; Stark AK; Okkenhaug K; Panoskaltsis-Mortari A; Sage PT; Sharpe AH; Luznik L; Ritz J; Soiffer RJ; Cutler CS; Koreth J; Antin JH; Miklos DB; MacDonald KP; Hill GR; Maillard I; Serody JS; Murphy WJ; Munn DH; Feser C; Zaiken M; Vanhaesebroeck B; Turka LA; Byrd JC; Blazar BR
Am J Transplant; 2019 Jun; 19(6):1820-1830. PubMed ID: 30748099
[TBL] [Abstract][Full Text] [Related]
9. IL-Y Aggravates Murine Chronic Graft-
Wan L; Jin Z; Hu B; Lv K; Lei L; Liu Y; Song Y; Zhu Y; Gong H; Xu M; Du Y; Xu Y; Liu H; Wu D; Liu Y
Front Immunol; 2020; 11():559740. PubMed ID: 33329519
[TBL] [Abstract][Full Text] [Related]
10. C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans.
Verghese DA; Chun N; Paz K; Fribourg M; Woodruff TM; Flynn R; Hu Y; Xiong H; Zhang W; Yi Z; Du J; Blazar BR; Heeger PS
JCI Insight; 2018 Dec; 3(24):. PubMed ID: 30568034
[TBL] [Abstract][Full Text] [Related]
11. Ezh2-mediated epigenetic modification is required for allogeneic T cell-induced lupus disease.
Zhen Y; Smith RD; Finkelman FD; Shao WH
Arthritis Res Ther; 2020 Jun; 22(1):133. PubMed ID: 32503684
[TBL] [Abstract][Full Text] [Related]
12. Altered immune reconstitution of B and T cells precedes the onset of clinical symptoms of chronic graft-versus-host disease and is influenced by the type of onset.
Bohmann EM; Fehn U; Holler B; Weber D; Holler E; Herr W; Hoffmann P; Edinger M; Wolff D
Ann Hematol; 2017 Feb; 96(2):299-310. PubMed ID: 27942862
[TBL] [Abstract][Full Text] [Related]
13. Donor CD8 T cell activation is critical for greater renal disease severity in female chronic graft-vs.-host mice and is associated with increased splenic ICOS(hi) host CD4 T cells and IL-21 expression.
Foster AD; Haas M; Puliaeva I; Soloviova K; Puliaev R; Via CS
Clin Immunol; 2010 Jul; 136(1):61-73. PubMed ID: 20451460
[TBL] [Abstract][Full Text] [Related]
14. "Age Related Differences in the Biology of Chronic Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation".
Cuvelier GDE; Li A; Drissler S; Kariminia A; Abdossamadi S; Rozmus J; Chanoine JP; Ng B; Mostafavi S; Brinkman RR; Schultz KR
Front Immunol; 2020; 11():571884. PubMed ID: 33193355
[TBL] [Abstract][Full Text] [Related]
15. Early and late extensive chronic graft-versus-host disease in children is characterized by different Th1/Th2 cytokine profiles: findings of the Children's Oncology Group Study ASCT0031.
Rozmus J; Schultz KR; Wynne K; Kariminia A; Satyanarayana P; Krailo M; Grupp SA; Gilman AL; Goldman FD
Biol Blood Marrow Transplant; 2011 Dec; 17(12):1804-13. PubMed ID: 21669298
[TBL] [Abstract][Full Text] [Related]
16. Chronic graft-versus-host disease (cGVHD) following unrelated donor hematopoietic stem cell transplantation (HSCT): higher response rate in recipients of unrelated donor (URD) umbilical cord blood (UCB).
Arora M; Nagaraj S; Wagner JE; Barker JN; Brunstein CG; Burns LJ; Defor TE; McMillan ML; Miller JS; Weisdorf DJ
Biol Blood Marrow Transplant; 2007 Oct; 13(10):1145-52. PubMed ID: 17889350
[TBL] [Abstract][Full Text] [Related]
17. B cell depleting therapy regulates splenic and circulating T follicular helper cells in immune thrombocytopenia.
Audia S; Rossato M; Trad M; Samson M; Santegoets K; Gautheron A; Bekker C; Facy O; Cheynel N; Ortega-Deballon P; Boulin M; Berthier S; Leguy-Seguin V; Martin L; Ciudad M; Janikashvili N; Saas P; Radstake T; Bonnotte B
J Autoimmun; 2017 Feb; 77():89-95. PubMed ID: 27863820
[TBL] [Abstract][Full Text] [Related]
18. T memory stem cells after allogeneic haematopoietic cell transplantation: unique long-term kinetics and influence of chronic graft-versus-host disease.
Jimbo K; Konuma T; Watanabe E; Kohara C; Mizukami M; Nagai E; Oiwa-Monna M; Mizusawa M; Isobe M; Kato S; Takahashi S; Tojo A
Br J Haematol; 2019 Sep; 186(6):866-878. PubMed ID: 31135974
[TBL] [Abstract][Full Text] [Related]
19. Follicular T helper cells and humoral reactivity in kidney transplant patients.
de Graav GN; Dieterich M; Hesselink DA; Boer K; Clahsen-van Groningen MC; Kraaijeveld R; Litjens NH; Bouamar R; Vanderlocht J; Tilanus M; Houba I; Boonstra A; Roelen DL; Claas FH; Betjes MG; Weimar W; Baan CC
Clin Exp Immunol; 2015 May; 180(2):329-40. PubMed ID: 25557528
[TBL] [Abstract][Full Text] [Related]
20. Reduced-intensity allogeneic transplant in patients older than 55 years: unrelated umbilical cord blood is safe and effective for patients without a matched related donor.
Majhail NS; Brunstein CG; Tomblyn M; Thomas AJ; Miller JS; Arora M; Kaufman DS; Burns LJ; Slungaard A; McGlave PB; Wagner JE; Weisdorf DJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):282-9. PubMed ID: 18275894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
